37 /100
MEDIUM RISK
Score updated May 30, 2026

ORKA — Oruka Therapeutics, Inc. Dilution Risk Tracker

Track ORKA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ORKA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
65
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
19%
💰 Capital Raise 38%
• Active shelf registration ($1000M, 28% of market cap)
• Active ATM program with $700M remaining capacity
🔔 Track ORKA — Get forecast alerts →

💹 Market Data

Market Cap$3.53B
Shares Outstanding60.31M
Float51.05M
Cash$388.83M
Debt$1.81M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 16.0% shares (2025Q4 vs prior)
141 institutional holders · 53.07M shares
#1 FMR LLC 7.26M shares
#2 VR ADVISER, LLC 4.15M shares
#3 Fairmount Funds Management LLC 3.71M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.25M
Days to Cover3.6
% of Float12.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
424B5 ATM Apr 29, 2026
424B5 ATM Apr 27, 2026
424B5 ATM Apr 27, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ORKA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ORKA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for ORKA
📊 ORKA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ORKA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.